NEW YORK, March 25 - Rosetta Biosoftware on Monday said it has licensed its Resolver gene-expression data-analysis system to Abbott Laboratories.
Financial terms of the deal were not disclosed, though Agilent Technologies, as usual, will distribute the bioinformatics tool.
The agreement is the second one in as many weeks for Rosetta, which licensed the Resolver system to Genencor on March 11.